The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.
This presentation provides a basic overview of AI governance in the United States for in-house attor...
The practice of law places legal professionals under extraordinary and often chronic stress, making ...
AI tools are advancing faster than legal organizations can absorb them. This program examines why th...
This program provides trial attorneys with a thorough grounding in the three principal currency repo...
This course on trade secrets litigation provides real-world best practices through all key stages of...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...
Class action waivers in arbitration agreements remain enforceable, but a decade of U.S. Supreme Cour...
This program provides a practical roadmap to mastering every stage of the discovery process in civil...
Data privacy remains one of the most rapid areas of growth in the class action space. Plaintiffs con...
Class action litigation continues to expand in both number of filings and monetary exposure, with se...